Don't Read Too Much Into AbbVie Case, FTC's Feinstein Says

The Federal Trade Commission's first pay-for-delay case after the U.S. Supreme Court's landmark Actavis Inc. ruling may have veered from the antitrust watchdog's typical approach to the suits, but that doesn't...

Already a subscriber? Click here to view full article